MedPath
HSA Approval

VEOZA™ FILM-COATED TABLETS 45 MG

SIN17196P

VEOZA™ FILM-COATED TABLETS 45 MG

VEOZA™ FILM-COATED TABLETS 45 MG

March 5, 2025

ASTELLAS PHARMA SINGAPORE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantASTELLAS PHARMA SINGAPORE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

G02CX06

Manufacturer Information

ASTELLAS PHARMA SINGAPORE PTE. LTD.

Astellas Pharma Inc. (Yaizu Technology Center)

Bushu Pharmaceuticals Ltd. (Misato Factory)

Active Ingredients

Fezolinetant

45.0mg

Fezolinetant

Documents

Package Inserts

Veoza Film-Coated Tablets PI.pdf

Approved: March 5, 2025

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

VEOZA™ FILM-COATED TABLETS 45 MG - HSA Approval | MedPath